AmeriLabs offers cancer risk panels for a variety of inherited conditions including breast, pancreatic, and renal cancers. We utilize next generation sequencing technology to analyze patient samples in a rapid and accurate manner. Specimens can be processed utilizing either saliva or cheek swab samples. We also work with healthcare providers to ensure medical necessity is met before specimen is processed, which reduces unnecessary testing.
Our broad testing profile allows physicians to identify a patient as a slow, intermediate, fast, or ultra-fast metabolizer of over 200 different drugs across 30 different drug classes. Our comprehensive Pharmacogenomics (PGx) profile includes genetic-metabolic relationships for antifungal, antiemetic, acid disorder, immunosuppressant, and urinary incontinence medications. Risk factors for thrombophilia, hyperhomocysteinemia, and dyslipidemia are also tested.